CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
MediGene AG Company Snapshot
MediGene AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other companies in this sector in Germany: Heidelberg Pharma Ag (2018 sales of 3.67 million Euro [US$4.06 million] ), Mologen AG (3.05 million Euro [US$3.37 million] of which 100% was Goods & Services), and 4Sc AG (4.17 million Euro [US$4.62 million] ).

Sales Analysis. MediGene AG reported sales of 7.75 million Euro (US$8.59 million) for the year ending December of 2018. This represents a sharp decrease of 24.7% versus 2017, when the company's sales were 10.30 million Euro. The sales level in 2018 was fairly close to the level five years ago: in 2013, MediGene AG had sales of 7.59 million Euro. Contributing to the drop in overall sales was the 42.8% decline in Outlincencedproducts, from 2.79 million Euro to 1.60 million Euro. . However, these declines were partially offset by the increase in sales of Immunotherapies (up 22.4% to 5.98 million Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
MediGene AG
  Stock Performance Chart for MediGene AG
 
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 5.50
(Figures in Euro)
1 Week -0.2%   13 Weeks -7.3%  
4 Weeks -14.7%   52 Weeks -34.5%  
 
MediGene AG Key Data:
  Ticker: MDG1 Country: Germany
  Exchanges: DUS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 7,754,000
(Year Ending Jan 2019).
Employees: 118
  Currency: Euro Market Cap: 135,094,619
  Fiscal Yr Ends: December Shares Outstanding: 24,562,658
  Share Type: Namenaktie Closely Held Shares: 2,491,499
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.